Noom Med vs SkinnyRx (2026): prices, structure, verdict

On tirzepatide, only SkinnyRx↗ has a rankable figure: $299 a month all-in; Noom Med↗ does not offer tirzepatide.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, the two are priced identically at $199 a month all-in — the decision moves entirely to structure.

§ Side by side

§ Each record, read aloud

The two records, condensed

Noom Med: the record, condensed

Noom Med’s semaglutide program bills $199 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $199 is the whole subscription, which makes Noom Med unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #12 of 20 in the verified semaglutide index — $66/month above the floor (Oak Longevity, $133) — and sits $150 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,388.

Operationally at Noom Med: shipping included; commitment 12-week cycles; cancellation 12-week billing cycles; pharmacy named (Tailor Made Compounding (named)); states: most states; evidence source-verified, captured 2026-08-08. The full record with source and archive links: the Noom Med page · visit Noom Med ↗

SkinnyRx: the record, condensed

On tirzepatide, the number that matters at SkinnyRx is $299 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes SkinnyRx unusually easy to compare and unusually easy to leave.

To place the number: #7 of 17 verified programs, with the floor $84/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $150 a month. A year at this figure: $3,588 monthly-billed.

On semaglutide, the number that matters at SkinnyRx is $199 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at SkinnyRx is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $199 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #11 of 20 in the verified semaglutide index — $66/month above the floor (Oak Longevity, $133) — and sits $150 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,388.

Operationally at SkinnyRx: shipping included; commitment none; cancellation no membership on compounded programs; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the SkinnyRx page · visit SkinnyRx ↗

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $199 (Noom Med) against $199 (SkinnyRx). $0 a month sounds survivable; $0 a year is a decision. At identical prices, everything below — structure, transparency, terms — is the whole comparison.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $0 gap is exactly what it appears to be.

Run the same two programs on the committed basis: Noom Med $199/mo month-to-month against SkinnyRx $199/mo month-to-month. The order holds: Noom Med leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Noom Med $597 monthly; SkinnyRx $597 monthly — best path favors Noom Med by $0. 6 months: Noom Med $1,194 monthly; SkinnyRx $1,194 monthly — best path favors Noom Med by $0. 12 months: Noom Med $2,388 monthly; SkinnyRx $2,388 monthly — best path favors Noom Med by $0. 24 months: Noom Med $4,776 monthly; SkinnyRx $4,776 monthly — best path favors Noom Med by $0.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: Noom Med publishes “most states”; SkinnyRx publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: Noom Med names its network (Tailor Made Compounding (named)); SkinnyRx does not, which shifts the burden of verification onto your intake questions.

Exit terms: Noom Med — 12-week cycles; 12-week billing cycles. SkinnyRx — none; no membership on compounded programs.

Evidence: Noom Med source-verified (captured 2026-08-08); SkinnyRx source-verified (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full semaglutide index these two sit at #12 and #11 of 20: between them lie 0 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Noom Med and SkinnyRx

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Noom Med: 12-week billing cycles; SkinnyRx: no membership on compounded programs) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings